EU CLOSE TO WRAPPING UP PRELIMINARY TALKS WITH U.S. FIRM NOVAVAX FOR THE SUPPLY OF POTENTIAL COVID-19 VACCINE - EU SOURCE
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.75 USD | +0.85% | +17.24% | -0.10% |
04-15 | Sector Update: Health Care Stocks Gain Monday Afternoon | MT |
04-15 | Global markets live: Goldman Sachs, Apple, Salesforce, Boeing Tesla... |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.10% | 657M | |
+24.78% | 48.09B | |
+47.36% | 40.62B | |
-3.08% | 40.43B | |
-6.20% | 28.36B | |
+7.61% | 24.89B | |
-19.42% | 19.01B | |
+29.71% | 12.09B | |
-0.60% | 11.88B | |
-0.24% | 11.8B |
- Stock Market
- Equities
- NVAX Stock
- News Novavax, Inc.
- Eu Close To Wrapping Up Preliminary Talks With U.s. Firm Novavax For The Supply Of Potential Covid-19 Vaccine - Eu Source